More than a hundred people were hospitalised for kidney disease, and five died after taking red yeast rice supplements. It is unclear what caused this health crisis, but Kobayashi Pharmaceutical, which makes the supplements, had known for months about health issues among its customers. After the COVID-19 pandemic, the supplements market has grown, also thanks to a labelling system that might have to be revised.
Health authorities searched a second Kobayashi Pharmaceutical factory in western Japan on Sunday after the company reported five deaths possibly tied to
TOKYO Health authorities searched a second Kobayashi Pharmaceutical factory in western Japan on March 31 after the company reported five deaths possibly tied to dietary supplements, an official said. The inspection in Wakayama prefecture followed a previous one on March 30 in Osaka, expanding the investigation into the drugmaker's use of "beni koji" red yeast materials. Osaka-based Kobayashi said.
Japanese government health officials are inspecting a factory that produces health supplements that have been linked to at least five deaths and the hospitalization of more than 100 others. The